US Patent 10954518 RAAV-based compositions and methods for treating amyotrophic lateral sclerosis

Is a

Patent

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

10954518

Patent Inventor Names

Robert H. Brown, Jr.0

Christian Mueller0

Date of Patent

March 23, 2021

Patent Application Number

16295621

Date Filed

March 7, 2019

Patent Citations

‌

US Patent 10166297 Isolation of novel AAV's and uses thereof

‌

US Patent 10280418 RAAV-based compositions and methods for treating amyotrophic lateral sclerosis

‌

US Patent 10300146 Isolation of novel AAV's and uses thereof

‌

US Patent 10597656 RAAV-based compositions and methods

‌

US Patent 10370432 Heterologous targeting peptide grafted AAVS

‌

US Patent 10711274 RAAV-based compositions and methods for treating amyotrophic lateral sclerosis

‌

US Patent 10072251 Recombinant AAVS having useful transcytosis properties

‌

US Patent 10077452 rAAV-based compositions and methods

Patent Primary Examiner

‌

Kimberly Chong

Patent abstract

The invention relates to inhibitory nucleic acids and rAAV-based compositions, methods and kits useful for treating Amyotrophic Lateral Sclerosis.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

US Patent 10954518 RAAV-based compositions and methods for treating amyotrophic lateral sclerosis

Contents

Patent attributes

Timeline

Further Resources

References

Find more entities like US Patent 10954518 RAAV-based compositions and methods for treating amyotrophic lateral sclerosis